Specifically, the Compassionate Access Act would “reschedule marijuana from its current position as a Schedule 1 drug under the Controlled Substances Act, which asserts the drug has no medical use and limits the ability of researchers to study the drug’s safety and effectiveness as a treatment”. This would “allow the states to provide appropriate access to patients needing these legitimate, medical treatments under the supervision of their physician”.
According to a press release, the proposal is supported by the Epilepsy Foundation, the American Academy of Neurology, and Americans for Safe Access.
“There are countless reports of marijuana’s medical benefits in treating conditions including cancer, epilepsy, and glaucoma”, says Representative Griffith. “It’s time to research this further, and, where legal, to allow real doctors and real pharmacists to prescribe or dispense marijuana for legitimate medical reasons for real patients.”
“Well over one million patients are currently benefitting from the medical use of marijuana in consultation with a physician and in accordance with state law,” says Representative Blumenauer. “Yet, all forms of marijuana use remain illegal at the federal level, classified as severely as heroin under the Controlled Substances Act.”
“This makes no sense”, he adds.